Strengthening Goethe University’s infrastructural capacity against the SARS-CoV-2 virus pandemic/COVID-19 lung disease (Q3303862): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in en: translated_label)
(‎Changed an Item: Edited by the infer coords bot - inferring coordiantes from postal codes)
Property / coordinate location
 
50°7'19.24"N, 8°39'56.16"E
Latitude50.122009794662
Longitude8.6656016941212
Precision1.0E-5
Globehttp://www.wikidata.org/entity/Q2
Property / coordinate location: 50°7'19.24"N, 8°39'56.16"E / rank
 
Normal rank

Revision as of 08:07, 26 October 2021

Project Q3303862 in Germany
Language Label Description Also known as
English
Strengthening Goethe University’s infrastructural capacity against the SARS-CoV-2 virus pandemic/COVID-19 lung disease
Project Q3303862 in Germany

    Statements

    0 references
    900,000.0 Euro
    0 references
    7 August 2020
    0 references
    31 December 2021
    0 references
    Johann Wolfgang Goethe-Universität Der Präsident
    0 references
    0 references

    50°7'19.24"N, 8°39'56.16"E
    0 references
    60323
    0 references
    Mit dem Eintreffen der nächsten COVID-19 Welle müssen Forschungsinfrastrukturen an der Goethe-Universität etabliert sein, die in ang emessener Zeit auf diese Ausnahmesituation reagieren können. a) Bestehende Forschungsprojekte außerhalb der Virus-Pandemie dürfen nicht zum Erliegen kommen.b) Zeitverluste müssen vermieden werden, z.B. durch Auslagerung an Fremdinstitute c) Höhere Sensitivität oder besser apparative Automatisierung optimiert Therapie-Maßnahmen / Wirkstoff-GenerierungDaher muss die Forschungsinfrastruktur durch Geräte-Beschaffungen gestärkt werden. (German)
    0 references
    With the arrival of the next COVID-19 wave, research infrastructures must be established at Goethe University, which can react to this exceptional situation in a reasonable time. a) Existing research projects outside the virus pandemic must not come to a standstill.b) Time losses must be avoided, e.g. by outsourcing to third-party institutes c) Higher sensitivity or better equipment automation optimises therapy measures/active substance generationTherefore, the research infrastructure must be strengthened by equipment procurement. (English)
    24 October 2021
    0 references

    Identifiers

    DE_TEMPORARY_6646
    0 references